ScoreWhy is Biocon Ltd. ?
1
The company has declared positive results in Dec'2025 after 2 consecutive negative quarters
- PAT(Latest six months) Higher at Rs 530.93 cr
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 4,601.10 cr
- DEBT-EQUITY RATIO(HY) Lowest at 0.62 times
2
With ROCE of 4.4, it has a Very Attractive valuation with a 1.9 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 11.46%, its profits have risen by 15.3%
3
Market Beating performance in long term as well as near term
- Along with generating 11.46% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Biocon should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biocon for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Biocon
11.46%
0.41
28.15%
Sensex
-2.38%
-0.19
12.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.66%
EBIT Growth (5y)
13.99%
EBIT to Interest (avg)
4.40
Debt to EBITDA (avg)
4.53
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
0.46
Tax Ratio
8.38%
Dividend Payout Ratio
5.92%
Pledged Shares
0
Institutional Holding
31.30%
ROCE (avg)
6.69%
ROE (avg)
5.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
69
Industry P/E
31
Price to Book Value
2.30
EV to EBIT
44.54
EV to EBITDA
20.59
EV to Capital Employed
1.93
EV to Sales
4.28
PEG Ratio
NA
Dividend Yield
0.11%
ROCE (Latest)
4.36%
ROE (Latest)
1.74%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
PAT(Latest six months)
Higher at Rs 530.93 cr
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 4,601.10 cr
DEBT-EQUITY RATIO(HY)
Lowest at 0.62 times
-6What is not working for the Company
PBT LESS OI(Q)
At Rs 108.30 cr has Fallen at -32.3% (vs previous 4Q average
ROCE(HY)
Lowest at 4.31%
NON-OPERATING INCOME(Q)
is 51.99 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Biocon
Profit After Tax (PAT) - Quarterly
At Rs 437.20 cr has Grown at 275.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 116.51 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 437.20 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 4,601.10 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Lowest at 0.62 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Biocon
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 108.30 cr has Fallen at -32.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 159.98 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 51.99 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Non Operating Income - Quarterly
Highest at Rs 117.30 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
